Infliximab therapy for Crohn's disease anoperineal lesions

To retrospectively evaluate the efficacy, the duration of response, and the tolerance of Remicade in anoperineal Crohn's disease. Fifty patients with severe symptomatic and refractory anoperineal Crohn's lesions (38 fistulae and 29 cavitating ulcers and superficial fissures) were treated w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastroentérologie clinique et biologique 2001-11, Vol.25 (11), p.949-956
Hauptverfasser:	Ouraghi, A, Nieuviarts, S, Mougenel, J L, Allez, M, Barthet, M, Carbonnel, F, Cosnes, J, Gendre, J P, Flourié, B, Meurisse, J J, Quandalle, P, Ernst, O, Lemann, M, Cortot, A, Modigliani, R, Colombel, J F
Format:	Artikel
Sprache:	fre
Schlagworte:	Abscess - epidemiology Adolescent Adult Aged Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Anus Diseases - drug therapy Anus Diseases - etiology Crohn Disease - complications Female Fissure in Ano - drug therapy Fissure in Ano - etiology Gastrointestinal Agents - adverse effects Gastrointestinal Agents - therapeutic use Humans Infliximab Male Middle Aged Perineum Rectal Fistula - drug therapy Rectal Fistula - etiology Recurrence Retrospective Studies Time Factors Treatment Outcome Tumor Necrosis Factor-alpha - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!